6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Original text

Rate this translation

Your feedback will be used to help improve Google Translate

Latest Press Releases

Time	Headline
11m ago	FatPipe Unveils VeloCloud Replacement Program with Price Match, 15% Discounts and 10% Partner Rebates
37m ago	Angle Advisors announces Shift Transit has been recapitalized by Main Street Capital Corporation
37m ago	Century Complete Announces New Homes Coming Soon to Fleming Island, FL
37m ago	Sprott Physical Copper Trust Announces Preliminary Proxy Results for Unitholder Meeting and Anticipated Listing Date on the NYSE Arca
38m ago	Tambourine & Hyatt Launch Hyatt Wedding Guide to Revolutionize Digital Wedding Planning

About

Cardiff Oncology Inc (NASDAQ:CRDF) — investor relations, events, news, and company updates on 6ix.

Latest News

Cardiff Oncology to Host Key Opinion Leader Discussion on Onvansertib’s Promising Single-Agent Activity

Cardiff Oncology Presents Preclinical Data on its PLK1 Inhibitor Onvansertib in Combination with a HER2-Targeted ADC at the 2026 AACR Annual Meeting

Cardiff Oncology Announces Key Leadership Appointments to Strengthen Executive Team for Next Phase of Growth

Cardiff Oncology to Host Key Opinion Leader Discussion Focusing on First-Line RAS-mutated Metastatic Colorectal Cancer

Cardiff Oncology to Present Preclinical Data with Highly Specific PLK1 Inhibitor Onvansertib at the 2026 AACR Annual Meeting

Financials

Revenue

$593 K

Market Cap

$108.02 M

EPS

-0.69

Community Chat

Ask AI